Home
Search results “Evista treatment for breast cancer”
Evista is a Prescription Medicine Used to Treat or Prevent Osteoporosis in Postmenopausal Women
 
00:45
http://www.rxwiki.com/evista Evista is a prescription medicine used to treat or prevent osteoporosis in postmenopausal women. It is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are at risk of invasive breast cancer. Evista belongs to a group of drugs called selective estrogen receptor modulators (SERMs). It works by mimicking the effects of estrogen to increase the density of bone. This medication comes in tablet form. It is taken once a day with or without food. Common side effects of Evista include hot flashes, leg cramps, swelling, and flu-like symptoms.
Views: 1273 RxWikiTV
Raloxifene retained approximately 81% effectiveness of tamoxifen preventing invasive breast cancer
 
02:36
Visit http://www.ecancer.org for more Dr Wickerham (NRG Oncology Research Group, Pittsburgh, USA) talks to ecancertv at ASCO 2015 about final updated results of the NRG Oncology/NSABP Protocol P-2: Study of Tamoxifen and Raloxifene (STAR) looking at preventing breast cancer.
Views: 1252 ecancer
Evista - Focus for the Cure
 
02:20
Dr. Donna Kleban Breast Surgeon
Views: 2223 komensouthflorida
Genetics May Guide Treatment for Women at High Risk for Breast Cancer
 
00:58
Tamoxifen and raloxifene are effective at preventing breast cancer in women at high risk for the disease. But they don't work for everyone, and can have dangerous side effects. A new study led by physicians at Allegheny General Hospital found that a genetic test can predict which women will be helped by tamoxifen or raloxifene. The research is an important step forward in fully individualized cancer care, said D. Lawrence Wickerham, MD, Director, Division of Cancer Genetics at AGH, in an interview with WPXI-TV. To learn more about the treatment of breast cancer, visit http://www.wpahs.org/specialties/cancer-institute/breast-cancer
AACR: Two Options for Breast Cancer Prevention
 
03:34
http://www.medpagetoday.com/MeetingCoverage/AACR/19653 WASHINGTON -- Women at high risk for breast cancer benefited from treatment with tamoxifen or raloxifene (Evista), according to long-term data from a large, randomized clinical trial. After a median follow-up of almost seven years, tamoxifen edged ahead of raloxifene for prevention of invasive breast cancers, which were 24% more common in the raloxifene group, investigators reported here at the American Association for Cancer Research meeting. Medpage Today: http://medpagetoday.com Online CME - Continuing medical education: http://www.medpagetoday.com/cme/ Latest medical news: http://www.medpagetoday.com/latest/ The MedPage Today app: iOS: https://goo.gl/JKrkHq Android: https://play.google.com/store/apps/details?id=com.medpagetoday.medpage MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageToday Medpage Today on Facebook: https://www.facebook.com/MedPageToday
Views: 140 MedPage Today
Evista (raloxifene) Tablets
 
03:29
Evista (raloxifene) is used to treat and prevent osteoporosis in postmenopausal women. Evista reduces the risk of vertebral fractures in women with postmenopausal osteoporosis.
Views: 181 Lynch's Pharmacy
BREAST CANCER Symptoms and Treatments
 
05:49
Breast cancer is cancer that develops from breast tissue.[1] Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin.[2] In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.[3] Risk factors for developing breast cancer include: female sex, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, and family history.[2][4] About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas.[2] In addition, there are more than 18 other sub-types of breast cancer. Some cancers develop from pre-invasive lesions such as ductal carcinoma in situ.[4] The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump. Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments it may respond to.[2] The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm.[5] A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age,[6] and the organization recommends screening every two years in women 50 to 74 years old.[7] The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it.[4] Surgical removal of both breasts is another useful preventative measure in some high risk women.[4] In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy.[2] Types of surgery vary from breast-conserving surgery to mastectomy.[8][9] Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.[9]
Views: 195 MedicTube
EVISTA
 
02:39
Views: 2098 northshore Inc.
Tamoxifen does not prevent Breast Cancer
 
14:10
Tamoxifen does not prevent Breast Cancer Tamoxifen is an antagonist of the estrogen receptor in breast tissue. Some breast cancer cells require estrogen to grow. Estrogen binds to and activates the estrogen receptor in these cells. Tamoxifen is metabolized into compounds that bind to the estrogen receptor but do not activate it. They only prevent estrogen from binding to its receptor Tumor evolves along the following stages: Stem cell transformation Estrogen dependence - Dysplasia - Carcinoma in situ - Carcinoma with receptors Estrogen independence - Carcinoma without receptors - Anaplastic carcinoma Estrogen is not a carcinogen. It does not transform a normal stem cell into a malignant. Estrogen promotes growth only of cells with estrogen receptors. Tamoxifen is metabolized into compounds that bind to the estrogen receptor but do not activate it. They only prevent estrogen from binding to its receptor. Tamoxifen is an anti-promoter, and not an anti-carcinogen! When they say "Prevention of Breast Cancer" they actually observe the slowing down of tumor growth. Tamoxifen does not prevent, it only slows down Medicine wake up! Stop these prevention trials and let these healthy women enjoy life without tamoxifen.
Views: 8672 Gershom Zajicek M.D,
Evista - Osteoporosis
 
01:14
Views: 8207 Jennifer Reece
Medicine Before Breast Cancer Strikes
 
00:37
http://www.dailyrx.com/breast-cancer-risk-reduced-women-taking-tamoxifen-and-evista http://www.dailyrx.com/conditions/breast-cancer-female Breast cancer risk may be reduced in at risk women taking certain medications. I'm Erin White and this is a dailyRx Minute. Women at risk for developing breast cancer may reduce their chances of developing the disease by nearly three-fold by taking medications such as Tamoxifen and Evista. The US Preventative Services Task Force is recommending at risk women between the ages of 40 and 70 discuss these medications with their doctors. Ask your doctor if preventative medication is right for you. For dailyRx TV, I'm Erin White.
Views: 198 dailyRx
13 Facts about Breast Cancer
 
01:57
http://www.factslides.com/s-Breast-Cancer Breast cancer is cancer that develops from breast tissue.[1] Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin.[2] In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.[3] Risk factors for developing breast cancer include being female, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, and family history.[2][4] About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas.[2] In addition, there are more than 18 other sub-types of breast cancer. Some cancers, such as ductal carcinoma in situ, develop from pre-invasive lesions.[4] The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump. Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments it may respond to.[2] The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm.[5] A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age,[6] and the organization recommends screening every two years in women 50 to 74 years old.[7] The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it.[4] Surgical removal of both breasts is another preventative measure in some high risk women.[4] In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy.[2] Types of surgery vary from breast-conserving surgery to mastectomy.[8][9] Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.[9] Outcomes for breast cancer vary depending on the cancer type, extent of disease, and person's age.[9] Survival rates in the developed world are high,[10] with between 80% and 90% of those in England and the United States alive for at least 5 years.[11][12] In developing countries survival rates are poorer.[4] Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases.[13] In 2012 it resulted in 1.68 million cases and 522,000 deaths.[13] It is more common in developed countries[4] and is more than 100 times more common in women than in men
2 More Side Effects of Tamoxifen
 
04:33
Find out more about Breast Cancer Index (BCI): http://www.breastcanceranswers.com/breastcancerindex/ As a continuation of our Hormone Therapy Side Effects Video, here are 2 more side effects from Tamoxifen you should be aware of. SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS http://www.youtube.com/user/drjayharness VISIT BREASTCANCERANSWERS.com FOR THE LATEST IN BREAKING BREAST CANCER NEWS http://www.breastcanceranswers.com/news SUBMIT A QUESTION http://www.breastcanceranswers.com/ DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR http://www.breastcanceranswers.com/ CONNECT WITH US! Google+: http://bit.ly/16nhEnr Facebook: https://www.facebook.com/BreastCancerAnswers Twitter: https://twitter.com/BreastCancerDr
New Drug Combinations Found to Treat Breast Cancer
 
00:44
20 (UPI) -- Scientists have discovered a new way to fight drug resistance in the treatment of breast cancer through bioinformatics. Researchers from the Institute for Research in Biomedicine in Barcelona, Spain, studied cell signaling networks in an effort to combat breast cancer cells from becoming resistant to certain types of drug treatment. The study analyzed 64 drugs used to treat breast cancer and identified 10 new drug combinations that could aid in the treatment of drug-resistant breast cancer. Resistance develops in about 15 percent of cases, as the activation of alternative molecular signaling pathways allows tumor cells to divide and avoid cell death. http://www.upi.com/Health_News/2016/12/20/Study-highlights-new-drug-combinations-to-treat-breast-cancer/8261482251716/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 243 Wochit News
Raloxifene
 
06:07
This video is about Raloxifene
Views: 2757 Shanu Mago
AACR 2010: Preventive treatment for breast cancer
 
02:38
Dr Judy Garber, of the Dana Farber Cancer Institute in Boston, USA, talks about the STAR trial, which looked at tamoxifen versus raloxifene as preventive treatment to lower breast cancer risk in high risk post-menopausal women. Speaking at the 2010 annual AACR conference.
Views: 284 ecancer
STAR study on breast cancer prevention
 
02:11
Norma Kreutz of Pittsburgh tells about her participation in the STAR study, comparing raloxifene and tamoxifen as preventative agents for women at high risk of breast cancer. Dr. Thomas Julian of Allegheny General Hospital comments on what the study means for high-risk women.
Breast cancer drug could help prevent the illness 2011 News
 
01:24
A patient undergoes a breast scan. In the UK scans like these are currently the main way hospitals detect and monitor breast cancer but leading cancer doctors now believe those at high risk should be offered medication. An international panel of experts believes the rising rate of breast cancer in Britain could be curbed if drugs were given to high-risk patients to try to prevent the illness. Trials of drugs already prescribed to treat breast cancer have shown signs of reducing the chances of patients developing the disease by around a third says a professor writing in the journal Lancet Oncology. The Cancer Research UK epidemiologist who produced the Lancet report writes There s strong evidence to show that drugs such as Tamoxifen are effective at preventing breast cancer in women with greater than average risk of the disease. Meg McArthur from charity Breakthrough Breast Cancer says It s vital that we do find more ways to effectively prevent breast cancer in the future particularly women who are at a high risk of developing the disease. But it s important to remember that this would not be appropriate for everyone. Doctors believe it is important to find better ways of predicting who will respond best to drug treatments so they can target those most likely to benefit and least likely to experience side-effects. According to doctors increased breast density is one of the leading risk factors for breast cancer and early trial results suggest that where Tamoxifen is shown to decrease density the risk of cancer decreases. Long-term studies still need to confirm this theory. However breast density could become a useful tool for identifying high-risk women who would benefit from the preventative treatments. Doctors are considering a range of drugs for breast cancer prevention including Tamoxifen and Raloxifene - which are licensed in the US. Also newer drugs - including Lasofoxifene Arzoxifene and aromatase inhibitors - have shown promising results but still need further investigation. Currently the drugs can cause side-effects including hot flushes blood clots and in some cases womb cancer. Although Tamoxifen and Raloxifene are licensed in the US neither is widely used. It is hoped that in the future it will be possible to assess women s breast cancer risk as part of routine breast screening and offer personalised advice about risk reduction and medicines for preventing breast cancer. Toral Shah who was given Tamoxifen when she was diagnosed with the disease at the age of 29 has mixed feelings about the proposed new use for the drug. I think they mustn t push it on people who don t really know even if they ve got a high risk because they may want to plan a different lifestyle. If it prevents people from having children or gives them a really bad poor quality of life then I don t think it s fair to push it on them she says. Breast cancer is on the rise with almost 50000 cases diagnosed every year in the UK according to Cancer Research
Views: 95 teyeodg jhtsyenb
Raloxifene
 
06:58
This video is about Raloxifene
Views: 666 Shanu Mago
What We Know About Preventing Breast Cancer 14
 
04:24
What We Know (And What We Need to Learn) About Preventing Breast Cancer Role of Raloxifene (Evista)/Tamoxifen in Reducing Breast Cancer Risk Response by: Marc E. Lippman, MD Clifford Hudis, MD
Personalized Breast Cancer Prevention
 
00:41
http://www.dailyrx.com/breast-cancer-prevention-therapy-effectiveness-varies-according-snp-variations http://www.dailyrx.com/conditions/breast-cancer-female The genetic make-up of a cancer can be critical information for treating the disease... and now scientists are wondering if that critical information could be useful before the caner ever forms. Scientists have discovered that variations on two genes could predict which women would benefit from breast cancer prevention therapy using tamoxifen and raloxifene. The genetic variations the scientists studied are called single nucleotide polymorphisms... or SNP's. Women who had favorable variations in the two SNPs were more likely to respond well to preventive therapy. Find out if genetic testing is right for you. For DailyRx TV, I'm Jennifer Dodd.
Views: 119 dailyRx
Breast Density & Increased Risk of Breast Cancer - Focus for the Cure
 
01:32
Dr. Robert Gardner Breast Surgeon, Center for Breast Care, Columbia Hospital
Views: 539 komensouthflorida
Raloxifene Meaning
 
00:18
Video shows what raloxifene means. A drug used in the treatment of osteoporosis. Raloxifene Meaning. How to pronounce, definition audio dictionary. How to say raloxifene. Powered by MaryTTS, Wiktionary
Views: 549 ADictionary
What Is Tamoxifen For Breast Cancer?
 
00:45
Tamoxifen in the treatment of breast cancer nejmbreast i care will not take tamoxifen mtamoxifen chemotherapy drugs chemocare. Tamoxifen in pill form (brand name nolvadex) breastcancer. Tamoxifen has both feb 17, 2014 tamoxifen been used as a treatment for women who have diagnosed with breast cancer roughly four decades and find out about drugs in hormone therapy. Examples of serms approved by the fda for treatment breast cancer are tamoxifen (nolvadex) and toremifene (fareston) jun 27, 2017 webmd looks at use drug treating preventing it in high risk cases about 2 out 3 cancers hormone receptor positive. Susan g tamoxifen in pill form (brand name nolvadex) breastcancer. Learn about tamoxifen at nov 26, 1998 review article from the new england journal of medicine in treatment breast cancer for over a quarter century, physicians have prescribed to help treat patients with advanced. In the 1990s, physicians began using breast cancer has a very high chance of being sensitive to hormone we should start you on tamoxifen pills straight away and keep them going for several (novladex) therapy side effects, how it's given, it works, precautions self care tips treatment jul 28, 2014 four types hormonal are fda approved early stage tamoxifen, exemestane, letrozole, anastrozole is most widely prescribed endocrine cancer, with more than 7. Food and drug administration (fda) to treat women men diagnosed with hormone receptor positive, early stage breast cancer after surgery (or possibly chemotherapy radiation) reduce the risk of coming back (recurring). Sep 17, 2012 breast cancer faq questions and answers. Answer tamoxifen (brand name nolvadex) is a medicine that very effective in preventing the selective estrogen receptor modulators (serms) bind to receptors, from binding. Komen breastcancer tamoxifen. Tamoxifen for breast cancer treatment side effects. Million woman years of clinical experience. The risk background in response to findings from the breast cancer prevention trial that tamoxifen treatment produced a 49 Tamoxifen pill form (brand name nolvadex) breastcancer. Hormone therapy for breast cancer fact sheet national tamoxifen treatment and prevention webmd. For breast cancer risk reduction, tamoxifen is typically taken for a total of five years. What are the side effects of tamoxifen? Breastcancer. While tamoxifen acts like an anti estrogen in breast cells, it other for women at higher risk of cancer, drugs such as and raloxifene have been shown to help reduce the is a hormone therapy drug used treat er cancer pre menopausal post men. Tamoxifen and other hormonal therapies for treating early stage risks benefits of tamoxifen therapy women at high risk breast cancer ncbi nihbreast in general chemoprevention medicines that reduce weighing the treatment. Googleusercontent search. Html url? Q webcache. Hormone therapy for breast cancer american society. Below shows how tamoxifen works. How you have it and other important information about taking tamoxifen
Views: 21 I Question You
Breast cancer prevention [ID 39114]
 
03:21
Video abstract of Review paper "Current strategies for the prevention of breast cancer" by Advani and Moreno-Aspitia published in the open access journal Breast Cancer: Targets and Therapy. Abstract: Due to the high incidence of breast cancer in the United States, optimal strategies for its prevention are imperative. This entails identification of women who are at an increased risk for breast cancer and an integrative approach that includes effective screening methods as well as nutritional, pharmacologic, and surgical management. Several breast cancer risk-assessment tools, such as the Gail and Claus models, can help clinicians determine the quantitative risk of breast cancer. The role of selective estrogen receptor modulators, such as tamoxifen and raloxifene, for the prevention of breast cancer has been well established. Several other agents, such as aromatase inhibitors, are currently being investigated. The potential adverse effects of these chemopreventive agents, which include an impact on the quality of life, must be discussed with the patient before deciding on this approach. Additionally, breast cancer risk factors have been identified over the years; some of them are modifiable, but others are not. Although there is no conclusive evidence to suggest the protective role of specific dietary components, alcohol consumption and obesity are associated with an increased breast cancer risk; thus lifestyle changes can lead to a lower risk of developing breast cancer. Surgical approaches, including bilateral risk-reduction mastectomy and salpingo-oophorectomy, are usually limited to women with a hereditary predisposition to development of breast cancer. The objective of this review is to summarize the various approaches directed at reducing the incidence of breast cancer. Read the full paper here:http://www.dovepress.com/current-strategies-for-the-prevention-of-breast-cancer-peer-reviewed-article
Views: 305 Dove Medical Press
RALOXIFENE: #1 Thing To Do RIGHT NOW If you don't want Gyno.
 
06:35
Click The Subscribe Button, and Hit the Notification Bell............. Formula Secrets Is Not Just About Arms & Abs. Be Alpha Today. *WARNING: DO NOT TRY THIS AT HOME This video is For Educational and Research Purposes only! The artist does believe however, that research videos do not have to be boring, or plain. The Personalities in These videos are intended to entertain viewers, while at the same time informing them on the experiences of others. Content within these videos are not to be mistaken for Medical Advice-Please Consult Your Personal Physician In Regards To Your Health* *ANY SUGGESTIONS CONTAINED WITHIN ARE DESIGNED AS A GUIDELINE, OBVIOUSLY EVERY PERSON IS DIFFERENT AND HAS DIFFERENT BACKGROUNDS AND DIFFERENT GENETIC TENDENCIES. IF YOU WOULD LIKE ADDITIONAL INFORMATION OR ANY INFORMATION CLARIFIED, YOU SHOULD CONTACT US DIRECTLY AT INFO@FORMULA-SECRETS.COM AND WE CAN ELABORATE FURTHER ON THIS SUBJECT MATTER FOR YOU* Kai is a professional. His results, and those of his top students, are not typical. Their experiences are not a guarantee you will get the same gains and body improvements. You may make more, less, or the same. Biggest Secret nobody is Doing.. That’s an easy answer right now… https://youtu.be/XWdLtczhG6Q I mean mostly only the elite are doing it right now..it’s cycling Gear. But most people are only doing small cycles, like Testosterone or Anavar… since they can’t afford to do the real cycles like Test stacked with Tren, Masteron and EQ.Hoops And they’re not really harnessing what you can really do with Home brewing. I’ve shown 1,000 competitive athletes how to do that, in the last couple of years. It’s pretty amazing and the results have blown me away. I’ll show you how to do in a step by step process. You can copy and use my formula that I've shared with my competitive athletes. Go right here. Do not miss these opportunities as you will regret it one day. https://youtu.be/XWdLtczhG6Q
Views: 1344 FormulaSecrets
What We Know About Preventing Breast Cancer 6
 
04:24
What We Know (And What We Need to Learn) About Preventing Breast Cancer Five-year Period for Tamoxifen / Raloxifene (Evista) Response by: Clifford Hudis, MD Walter C. Willett, MD, DrPH
Dr. Harvey Discusses Preventing Breast Cancer
 
01:33
Harold A. Harvey, MD, Professor of Medicine, Director, Hematology/Oncology Fellowship Program, Penn State Hershey Cancer Institute, explains that he is excited about the advances that have taken place in the field of treating breast cancer and is happy with the progress that has been made so far. Harvey feels the biggest step in the future will be preventing breast cancer from ever occurring, which he feels we are falling behind in. Methods exist to prevent some forms of breast cancer, but these are not being widely applied. Although oncologists can play a role in counseling a patient's relatives the role of preventive medicine generally falls on the hands of the primary care physician. Some of the preventive methods available, such as tamoxifen or evista, are difficult to take because of possible side effects. Lifestyle changes, such as diet, weight control, and avoiding obesity are all preventive measures that individuals need to consider.
Views: 106 OncLiveTV
Osteoporosis drug is approved for prevention of breast cance
 
02:32
On this edition of oncology podcasting news, an osteoporosis drug is approved for prevention of breast cancer; and resistance training and yoga enhances breast cancer patients' quality of life and physical condition.
Views: 1651 OncologyPodCasting
Breast cancer and osteoporosis:  the link between them
 
02:21
Powerful chemotherapy drugs and estrogen-blocking hormone treatments are highly effective in treating breast cancer. But in the process they may be putting women at risk of another disease: osteoporosis.
Views: 1776 Michigan Medicine
Dr. Tripathy Discusses Breast Cancer Prevention
 
01:23
Debu Tripathy, MD, co-leader of the Women's Cancer Program at the Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, discusses the use of pharmaceuticals to prevent the occurrence of contralateral breast cancer. Tripathy explains that it has been known for some time that tamoxifen and aromatase inhibitors can lower the risk of developing a new contralateral tumor. The efficacy of these agents has been further supported in newer trials showing an approximate 50% reduction in new tumors. More recently the focus has shift towards the agent raloxifene, which seems to cause fewer side effects, such as endometrial cancer and deep venous thrombosis. The side effect profile remains a concern because the available risk stratification tools make it difficult to predict which patients will contrive the highest benefit. The tools are reasonably accurate on a broad population level, but lose their efficacy on an individual basis. The inability to predict responses has led to the infrequent use of preventive agents. More research is needed to help predict the patients that will benefit the most and to reduce the side effects associated with the treatments.
Views: 136 OncLiveTV
Oncology: Looking at Receptors for Breast Cancer Treatment Options
 
01:55
They are called receptors, and they continue to be a major focal point when it comes to treating breast cancer. In today's Health Matters segment, Dr. Eric Goldsmith, D.O., discusses how these receptors are guiding scientists toward new treatment options. Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we've been providing residents like you with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit www.leememorial.org/caring
Views: 473 Lee Health
IMPAKT 2013: Long-term effectiveness of SERMs for preventing breast cancer
 
08:16
World-leading epidemiologist Prof Jack Cuzick talks to ecancer about his paper in the Lancet confirming that selective estrogen receptor modulators (SERMs) are both effective and safe for preventing breast cancer in women who are at high risk of the disease but who are not ill. There has been caution about using tamoxifen and raloxifene (both SERMs) following scare stories in the US: Prof Cuzick's meta analysis addreses this and brings hope of avoiding a third of breast cancers.
Views: 368 ecancer
Internal Medicine Board Review: Breast Cancer. Presented by Brigham.
 
06:34
In this segment, Dr. Lawrence Shulman discusses 5 important topics of breast cancer: • Epidemology-estrogen increases risk of breast cancer • Prevention-tamoxifen and raloxifene can reduce risk of developing breast cancer but doens not reduce mortality • Screening- mammography remains a mainstay for early diagnosis of breast cancer • Primary, non-metastic, breast cancer- molecular subtypes of breast cancer drive appropriate therapy • Metastatic Breast Cancer- Survival still poor but new bilogic agents hope for better survivals. To learn more or purchase the program: http://www.cmeinfo.com/store_temp/proddetails.asp?prodcat=642?trackcode=WEB14001
Views: 500 cmeinfochannel
Genetic Test May Help Women at High Risk for Breast Cancer
 
01:54
A research study led by physicians at Allegheny General Hospital found that a certain genetic variation will predict whether women at high risk for breast cancer will respond to the preventive drugs tamoxifen and raloxifene. The findings from the study of more than 600 high-risk women are a step forward toward a time when all cancer care is tailored to a patient's individual genetics, said Dr. Thomas Julian, Director of Breast Surgical Oncology at Allegheny General, in an interview with KDKA-TV. To learn more about the treatment of breast cancer, visit http://www.wpahs.org/specialties/cancer-institute/breast-cancer
Menopause periods - Selective Estrogen Receptor Modulators
 
06:02
Selective Estrogen Receptor Modulators http://menopauseperiods.mymenopauseonline.com/ SERMs are a category of drugs, either synthetically produced or derived from a botanical source (Phytoserms), that act selectively as agonists or antagonists on the estrogen receptors throughout the body. The most commonly prescribed SERMs are raloxifene and tamoxifen. Raloxifene exhibits oestrogen agonist activity on bone and lipids, and antagonist activity on breast and the endometrium.Tamoxifen is in widespread use for treatment of hormone sensitive breast cancer. Raloxifene prevents vertebral fractures in postmenopausal, osteoporotic women and reduces the risk of invasive breast cancer. While most SERMs are known to increase hot flushes, Femarelle (DT56a) decreases them. In addition to the relieving effects on menopausal symptoms, Femarelle also increases bone mass density (BMD), making it protective against osteoporotic fractures. These effects are achieved by an agonistic interaction with estrogen receptors in the brain and bone. On the other hand, an antagonist interaction with estrogen receptors in the breast and uterus, has no effect on these tissues. [edit] Antidepressants Antidepressants such as paroxetine (Paxil), Fluoxetine hydrochloride (Prozac), and Venlafaxine hydrochloride (Effexor) have been used with some success in the treatment of hot flashes, improving sleep, mood, and quality of life. Paroxetine and venlafaxine may cause nausea and insomnia. In addition, venlafaxine may cause dry mouth, constipation and decreased appetite whereas paroxetine may cause headaches. There is a theoretical reason why SSRI antidepressants might help with memory problems: they increase circulating levels of the neurotransmitter serotonin in the brain and restore hippocampal function. Fluoxetine hydrochloride (Sarafem) is also prescribed for premenstrual dysphoric disorder (PMDD), a mood disorder often exacerbated during perimenopause. PMDD has been found by PET scans to be associated with dysregulation of serotonin pathways in the brain and to respond quickly and powerfully to SSRIs. Gabapentin Gabapentin (sometimes called by its brand name, Neurontin) and other GABA analogs are anti-seizure medications. Several GABA analogs are prescribed off-label for a variety of other conditions (such as pregabalin being used to treat the symptoms of fibromyalgia under the brand name Lyrica); gabapentin itself has been shown to be as effective as estrogen at reducing hot flashes. Blood pressure medicines Blood pressure medicines including clonidine (Catapres) are about as effective as antidepressants for hot flashes, but do not have the other mind and mood benefits of antidepressants. However they may merit special consideration by women suffering both from high blood pressure and hot flashes.
Views: 4750 mymenopauseonline
Dr. Muss Discusses Tamoxifen as Breast Cancer Prevention
 
02:50
Hyman B. Muss, MD, professor of oncology, University of North Carolina, director, Geriatric Oncology, Lineberger Comprehensive Cancer Center, discusses tamoxifen as breast cancer prevention.
Views: 136 OncLiveTV
Raloxifene prevents breast cancer!-Η ραλοξιφένη προλαμβάνει τον καρκίνο του μαστού!
 
01:08
Υπάρχει ουσία που μπορούν να λάβουν καθημερινά οι γυναίκες, ώστε να προλαμβάνουν τον καρκίνο του μαστού; Ναι! Η ραλοξιφένη: http://www.galinos.gr/web/drugs/main/packages/18395 http://www.galinos.gr/web/drugs/main/packages/18397 http://www.galinos.gr/web/drugs/main/packages/23808 http://www.galinos.gr/web/drugs/main/packages/1686 http://www.bmj.com/content/346/bmj.f2891 Raloxifene administration prevents breast cancer in postmenopausal women!
Views: 47 fastandeffective
Estrogen-Receptor Binding Mode Raloxifene
 
00:28
chimica computazionale
Views: 4452 Simone Brogi
Dr. Davidson Discusses Breast Cancer Chemoprevention
 
00:58
Nancy E. Davidson, MD, director, University of Pittsburgh Cancer Institute and UPMC Cancer Centers, discusses breast cancer chemoprevention, which uses pharmaceuticals to prevent or delay the development of cancer. Davidson explains that a great deal of research has been done into chemoprevention in breast cancer, mostly with the selective estrogen receptor modulators (SERMs), tamoxifen and raloxifene. There have been numerous randomized trials that demonstrated positive results. However, these trials did not produce the widespread adaptation of SERMs for chemoprevention. The agents tamoxifen and raloxifene are both approved for breast cancer risk reduction in high-risk patients. There is information available that suggest aromatase inhibitors can also prevent breast cancer, but they are not an FDA approved intervention. According to Davidson, the puzzle of chemoprevention is that trials with tens of thousands of women over decades have not been applied, despite positive results with several agents.
Views: 145 OncLiveTV
Overcoming Endocrine Resistance in Breast Cancer
 
05:42
Ingrid A. Mayer, MD, MSCI, examines pathways that may help overcome endocrine resistance in breast cancer.
Views: 168 OncLiveTV
Latest Estrogen Receptor Positive Breast Cancer Information
 
25:15
This power point presentation was given by Dr. Joe Veltmann on August 28th in Guadalajara, Mexico before 200+ medical doctors who heard Dr. Bernard Esquivel speak about pharmacogenomics and Dr. Veltmann about the ER + breast cancer research and how nutrigenomics may play a role in preventing its recurrence.
Views: 1615 Joe Veltmann
When Was The First Case Of Breast Cancer Found?
 
00:46
History of breast cancer maurer foundation. History of breast cancer maurer foundation history news medical health. Breast cancer symptoms and treatment patient understanding breast the long winding road. A brief history of breast cancer timeline healthlinefirst diagnosisamerican societythe atlasbreast seen in ancient egyptian symptoms, risk factors, and treatment. Evidence of cancer cells in dinosaur fossils, found 2003. Treatment of early breast cancer. Million ancient egyptian scrolls describe eight cases of breast tumors treated by cauterization the oldest evidence cancer was discovered in egypt 2015 first case controlled study on epidemiology 25 mar seen archaeologists say they may have found world's a this isn't time researchers 17 jul 2017 symptoms are usually an area thickened with cosmetic implants who diagnosed surgery is line treatment for unless tumor very large or has spread to other parts body, which chemotherapy expert doctors answer your questions about inflammatory. For example, the edwin smith surgical papyrus describes cases of breast cancer. Most patients present having found a painless lump in the breast 27 jan 2017 cancer reportedly accounted for 29 History of maurer foundation. Googleusercontent search. Check out the history 15 mar 2017 breast cancer has been studied since ancient times. Aspx url? Q webcache. 22 sep 2013 ancient egyptians were the first to note the disease more than 3,500 years ago. Paget's disease of the breast cancer research uk. Suggests the molecular abnormalities that can be found in inflammatory breast cancer first round of chemo was well tolerated, surgery and radiation also performed 20 jul 2016 learn more about who gets as treatment for. Invasive it is found in 1 to 4 out of every 100 breast cancers (1. One large study found about 90 percent of women diagnosed between in some cases, radiation therapy is used after mastectomy to treat the chest wall and axillary nodes 3 jul 2016 inflammatory carcinoma occurs a small minority all cases with rapidly growing, sometimes family history breast cancer first degree relative. I'm not sure if this is what happened in your particular case. Who gets chemotherapy as treatment? Breast cancer symptoms, treatment & prevention live science. A brief history of breast cancer ncbi nih. In some cases, chemotherapy may be used before surgery to shrink the tumor for women diagnosed with early stage breast cancer if is 13 mar 2015 in about 5 10 percent of genetic mutations are not everyone will have symptoms they. 2006 the drug raloxifene is found to reduce breast cancer risk for postmenopausal the american cancer society has compiled an overview of how people have understood & described cancer throughout history, as well as treatment evolution 12 jun 2014 some of the earliest evidence of cancer is found among fossilized bone tumors it describes 8 cases of tumors or ulcers of the breast that were explore a timeline of the history of cancer from 18th century bce to 2011.
Use of SERMS in BODYBUILDING | LIFE STYLE VLOG
 
10:28
SERMS- Selective ESTROGEN receptor modulators. Approval- Approved by FDA (US) as safe medicine. SERMS for PCT- Clomiphene Citrate ( CLOMID) - Raloxifene (Evista) - Tamoxifen Citrate ( NOLVADEX) What serms actually does ? - IT delivers all the benefits of Estrogen without the adverse side effects concerning it . SERMS used for muscle gain- Mupostarine -(OSTARINE- MK2866) Testolone- (RAD 140) Few more are there also. LIFE TIME - 24hrs DOSES - For 25mg per day for 4-6 weeks for bulking.(MK 2866) 12.5-15 mg per day for 4-6 weeks for cutting .(MK 2866) Anabolic property - even at low dose of 3mg Benefits- Increase lean mass gain Better Strength More Endurence Joint healing abilities Cure for muscle wasting Use for treatment of Osteoporosis Use for treatment of low bone density issue . Use for treatment of few types of breast cancer . Durable upto 6months or 24 weeks .. in using Click the link below to "SUBSCRIBE" to my channel. https://www.youtube.com/channel/UCryVyOe2qYxZhJzuzft3f8A?view_as=subscriber ***************************************************** MY CONTACT information - Facebook- https://www.facebook.com/niladri.basu1 Instagram- https://www.instagram.com/niladri_basu2005/ ****************************************************
Views: 1954 LIFE STYLE VLOG